-
2
-
-
28444498381
-
Prognostic factors for mesothelioma
-
Steele JP. Prognostic factors for mesothelioma. Hematol Oncol Clin North Am 2005; 19: 1041-1052, vi.
-
(2005)
Hematol Oncol Clin North Am
, vol.19
-
-
Steele, J.P.1
-
3
-
-
58149083475
-
Systemic treatments for mesothelioma: standard and novel
-
Kindler HL. Systemic treatments for mesothelioma: standard and novel. Curr Treat Options Oncol 2008; 9: 171-179.
-
(2008)
Curr Treat Options Oncol
, vol.9
, pp. 171-179
-
-
Kindler, H.L.1
-
4
-
-
12444273659
-
Gene expression profiling of malignant mesothelioma
-
Singhal S, Wiewrodt R, Malden LD et al. Gene expression profiling of malignant mesothelioma. Clin Cancer Res 2003; 9: 3080-3097.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3080-3097
-
-
Singhal, S.1
Wiewrodt, R.2
Malden, L.D.3
-
5
-
-
21144456382
-
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using largescale transcriptional profiling
-
Gordon GJ, Rockwell GN, Jensen RV et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using largescale transcriptional profiling. Am J Pathol 2005; 166: 1827-1840.
-
(2005)
Am J Pathol
, vol.166
, pp. 1827-1840
-
-
Gordon, G.J.1
Rockwell, G.N.2
Jensen, R.V.3
-
6
-
-
33645515866
-
Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction
-
Lopez-Rios F, Chuai S, Flores R et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 2006; 66: 2970-2979.
-
(2006)
Cancer Res
, vol.66
, pp. 2970-2979
-
-
Lopez-Rios, F.1
Chuai, S.2
Flores, R.3
-
7
-
-
70349277287
-
Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target
-
Crispi S, Calogero RA, Santini M et al. Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target. PLoS One 2009; 4: e7016.
-
(2009)
PLoS One
, vol.4
-
-
Crispi, S.1
Calogero, R.A.2
Santini, M.3
-
8
-
-
84880273681
-
Molecular pathogenesis of malignant mesothelioma
-
Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis 2013; 34: 1413-1419.
-
(2013)
Carcinogenesis
, vol.34
, pp. 1413-1419
-
-
Sekido, Y.1
-
9
-
-
71849098457
-
Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells
-
Sekido Y. Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci 2010; 101: 1-6.
-
(2010)
Cancer Sci
, vol.101
, pp. 1-6
-
-
Sekido, Y.1
-
10
-
-
80052356301
-
Advances in the biology of malignant pleural mesothelioma
-
Zucali PA, Ceresoli GL, De Vincenzo F et al. Advances in the biology of malignant pleural mesothelioma. Cancer Treat Rev 2011; 37: 543-558.
-
(2011)
Cancer Treat Rev
, vol.37
, pp. 543-558
-
-
Zucali, P.A.1
Ceresoli, G.L.2
De Vincenzo, F.3
-
11
-
-
79955562300
-
Review on clinical trials of targeted treatments in malignant mesothelioma
-
Jakobsen JN, Sorensen JB. Review on clinical trials of targeted treatments in malignant mesothelioma. Cancer Chemother Pharmacol 2011; 68: 1-15.
-
(2011)
Cancer Chemother Pharmacol
, vol.68
, pp. 1-15
-
-
Jakobsen, J.N.1
Sorensen, J.B.2
-
12
-
-
15744373791
-
Pathology and Genetics of Tumours of the Lung, Pleura
-
Thymus Heart. IARC World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer (IARC)
-
Travis WD, M-HHK BE, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura. Thymus Heart. IARC World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer (IARC), 2004.
-
(2004)
-
-
Travis, W.D.1
M-Hhk, B.E.2
Harris, C.C.3
-
13
-
-
34247333444
-
The spindle-assembly checkpoint in space and time
-
Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8: 379-393.
-
(2007)
Nat Rev Mol Cell Biol
, vol.8
, pp. 379-393
-
-
Musacchio, A.1
Salmon, E.D.2
-
14
-
-
0036018904
-
Malignant pleural mesothelioma: a phase II trial with docetaxel
-
Vorobiof DA, Rapoport BL, Chasen MR et al. Malignant pleural mesothelioma: a phase II trial with docetaxel. Ann Oncol 2002; 13: 412-415.
-
(2002)
Ann Oncol
, vol.13
, pp. 412-415
-
-
Vorobiof, D.A.1
Rapoport, B.L.2
Chasen, M.R.3
-
15
-
-
45549107234
-
Novel cytotoxic agents: epothilones
-
Goodin S. Novel cytotoxic agents: epothilones. Am J Health Syst Pharm 2008; 65: S10-S15.
-
(2008)
Am J Health Syst Pharm
, vol.65
-
-
Goodin, S.1
-
16
-
-
33845986330
-
Mad2 overexpression promotes aneuploidy and tumorigenesis in mice
-
Sotillo R, Hernando E, Diaz-Rodriguez E et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007; 11: 9-23.
-
(2007)
Cancer Cell
, vol.11
, pp. 9-23
-
-
Sotillo, R.1
Hernando, E.2
Diaz-Rodriguez, E.3
-
17
-
-
77949773695
-
Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
-
Sotillo R, Schvartzman JM, Socci ND et al. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010; 464: 436-440.
-
(2010)
Nature
, vol.464
, pp. 436-440
-
-
Sotillo, R.1
Schvartzman, J.M.2
Socci, N.D.3
-
18
-
-
79958733630
-
Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition
-
Schvartzman JM, Duijf PH, Sotillo R et al. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 2011; 19: 701-714.
-
(2011)
Cancer Cell
, vol.19
, pp. 701-714
-
-
Schvartzman, J.M.1
Duijf, P.H.2
Sotillo, R.3
-
19
-
-
78650569571
-
Phosphorylation of the spindle checkpoint protein Mad2 regulates its conformational transition
-
Kim S, Sun H, Ball HL et al. Phosphorylation of the spindle checkpoint protein Mad2 regulates its conformational transition. Proc Natl Acad Sci USA 2010; 107: 19772-19777.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 19772-19777
-
-
Kim, S.1
Sun, H.2
Ball, H.L.3
-
20
-
-
0033758034
-
Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells
-
Percy MJ, Myrie KA, Neeley CK et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 2000; 29: 356-362.
-
(2000)
Genes Chromosomes Cancer
, vol.29
, pp. 356-362
-
-
Percy, M.J.1
Myrie, K.A.2
Neeley, C.K.3
-
21
-
-
62549089719
-
Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies
-
Bolanos-Garcia VM. Assessment of the mitotic spindle assembly checkpoint (SAC) as the target of anticancer therapies. Curr Cancer Drug Targets 2009; 9: 131-141.
-
(2009)
Curr Cancer Drug Targets
, vol.9
, pp. 131-141
-
-
Bolanos-Garcia, V.M.1
-
22
-
-
79953299183
-
Drugs that target dynamic microtubules: a new molecular perspective
-
Stanton RA, Gernert KM, Nettles JH et al. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 2011; 31: 443-481.
-
(2011)
Med Res Rev
, vol.31
, pp. 443-481
-
-
Stanton, R.A.1
Gernert, K.M.2
Nettles, J.H.3
-
23
-
-
78049423380
-
Ixabepilone, a new treatment option for metastatic breast cancer
-
Toppmeyer DL, Goodin S. Ixabepilone, a new treatment option for metastatic breast cancer. Am J Clin Oncol 2010; 33: 516-521.
-
(2010)
Am J Clin Oncol
, vol.33
, pp. 516-521
-
-
Toppmeyer, D.L.1
Goodin, S.2
-
24
-
-
85027951919
-
Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B
-
Rogalska A, Marczak A, Gajek A et al. Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B. Toxicol In Vitro 2013; 27: 239-249.
-
(2013)
Toxicol In Vitro
, vol.27
, pp. 239-249
-
-
Rogalska, A.1
Marczak, A.2
Gajek, A.3
-
25
-
-
0034518173
-
Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics
-
Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell Dev Biol 2000; 16: 89-111.
-
(2000)
Annu Rev Cell Dev Biol
, vol.16
, pp. 89-111
-
-
Downing, K.H.1
-
26
-
-
84859169877
-
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
-
Barretina J, Caponigro G, Stransky N et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-607.
-
(2012)
Nature
, vol.483
, pp. 603-607
-
-
Barretina, J.1
Caponigro, G.2
Stransky, N.3
-
27
-
-
84876563391
-
Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
-
Yang W, Soares J, Greninger P et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 2013; 41: D955-D961.
-
(2013)
Nucleic Acids Res
, vol.41
-
-
Yang, W.1
Soares, J.2
Greninger, P.3
|